You are invited to join EASL at the European Parliament, Brussels, Belgium, for the launch of the research roadmap for liver disease 'HEPAMAP'.
The HEPAMAP is an advocacy tool written specifically for European hepatologists to highlight the further research needed with a view to influencing the EU research agenda, but also to raise awareness of liver disease more generally and its links with lifestyle factors such as obesity and alcohol, as well as with metabolic and cardiovascular disease and cancer.
A nuclear receptor links HIV drugs with liver disease
Physical activity linked to reduced risk of liver cancer
MICROB-PREDICT – €15 million EU funded microbiome research project kicks off